EP PerMed 2027 – Cell and Gene Therapy for Personalised Medicine

Reference: TUBITAK-EPPERMED-CGT4PM2027

International personalised-medicine research call announced 10 November 2026; Stage 1 international deadline 20 January 2027 and Türkiye national deadline 27 January 2027.

Funding source: European Partnership For Personalised Medicine; Tübi̇tak
Programme: Ep Permed Jtc2027
Funding call: Cell And Gene Therapy For Personalised Medicine (Cgt4Pm2027)
Opening date: 10.11.2026 00:00
Deadline: 20.01.2027 14:00

About this opportunity

Joint transnational call on innovative cell and gene therapies for personalised medicine. Türkiye participates through TÜBİTAK 1071.

Objectives

Fund research developing and validating innovative cell and gene therapy approaches for personalised medicine.

Budget

Eligible applicants

Research Organisations Universities Eligible Consortium Partners

Countries

🇹🇷 Türkiye

Sectors

Health R&D Personalised Medicine Cell Therapy Gene Therapy

Application access

Some details are available on our Free plan — log in or register to unlock them. Full details on every opportunity are reserved for Pro & Organisation members.